| Literature DB >> 34670550 |
Umile Giuseppe Longo1, Alessandro Mazzola2, Simone Carotti3, Maria Francesconi3, Simone Catapano2, Francesco Magrì2, Giuseppe Perrone4, Sergio Morini3, Sergio De Salvatore2, Vincenzo Denaro2.
Abstract
BACKGROUND: Rotator cuff (RC) tears represent a common cause of shoulder pain and dysfunction in adults. The disease affects primarily women and occurs mainly in the postmenopausal period. This study aimed to investigate immunohistochemically the presence of estrogen receptor-alpha (ER-⍺), estrogen receptor-beta (ER-β) and progesterone receptor (PR) in the supraspinatus tendon of patients with RC tendinopathy, searching for gender differences of expression. A secondary aim was to evaluate potential links between their expression and the typical histopathological findings of the ailment.Entities:
Keywords: Cuff; Estrogen; Immunohistochemistry; Progesterone; Receptor; Rotator; Tendinopathy
Mesh:
Substances:
Year: 2021 PMID: 34670550 PMCID: PMC8529750 DOI: 10.1186/s12891-021-04778-5
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Demographic data of the female population with RC disease
| Patient number | Age at surgery | Age at Menopause | Hormone replacement therapy | Hormone suppression therapy | Body Mass Index (BMI) | Type of tendon injuries (small; medium; large; massive) | Time from injury/shoulder pain | Treatments performed before surgery |
|---|---|---|---|---|---|---|---|---|
| 1 | 73 | 53 | no | yes | 29.3 | Atraumatic - massive | 6 years | Physical therapy |
| 2 | 64 | 54 | yes | yes | 34.9 | Atraumatic - massive | 6 months | none |
| 3 | 58 | 49 | no | no | 37.7 | Atraumatic - massive | 2 years | none |
| 4 | 58 | 53 | no | no | 20.0 | Atraumatic - medium | 2 years | none |
| 5 | 69 | 51 | no | no | 29.9 | Atraumatic - massive | 6 years | none |
| 6 | 61 | 51 | no | no | 24.2 | Atraumatic - large | 8 months | Physical therapy |
| 7 | 59 | 52 | no | no | 26.9 | Traumatic - medium | 1 year | none |
| 8 | 74 | 55 | no | no | 26.0 | Atraumatic - massive | 2 years | none |
| 9 | 79 | 50 | no | no | 25.4 | Atraumatic - medium | 5 months | none |
| 10 | 74 | 48 | no | no | 26.0 | Atraumatic - massive | 2 years | none |
| 11 | 62 | 50 | yes | yes | 27.4 | Atraumatic - medium | 1 year | Physical therapy |
| 12 | 61 | 53 | no | no | 24.2 | Traumatic - large | 3 months | none |
| 13 | 66 | 51 | no | no | 30.1 | Atraumatic - medium | 2 years | Corticosteroid injections |
| 14 | 68 | 49 | no | no | 25.0 | Traumatic -large | 2 years | none |
| 15 | 55 | 50 | no | no | 29.0 | Atraumatic – medium | 6 months | none |
Female population: Mean age 63.93 ± 7.05; Mean age at surgery 65.41 ± 6.94; Mean age at menopause 51.27 ± 1.95; Mean BMI 27.73 ± 4.24; Mean duration of symptoms 22.67 ± 20.93 months. Full-thickness rotator cuff tears were classified into the numbers of tendons torn: small lesions (< 1 cm of tear and < 1 tendon involved); medium lesions (1–3 cm of tear and 1 tendon involved); large (3–5 cm of tear and 2 tendons involved); massive (> 5 cm of tear and > 2 tendons involved). Partial-thickness rotator cuff tears were graded in a binary fashion as either grade 1 (less than 50% torn) or grade 2 (more than 50% torn) and according to the side torn (either articular or bursal)
Demographic data of the male population with RC disease
| Patient number | Age at surgery | Hormonal therapy | Body Mass Index (BMI) | Type of tendon injuries | Time from injury / shoulder pain | Treatments before surgery |
|---|---|---|---|---|---|---|
| 1 | 54 | no | 32.2 | Traumatic - massive | 1 year | none |
| 2 | 51 | no | 28.0 | Atraumatic - large | 2 years | Corticosteroid injections |
| 3 | 55 | no | 27.7 | Traumatic - medium | 2 months | none |
| 4 | 77 | no | 26.9 | Atraumatic - massive | 1 year | none |
| 5 | 62 | no | 29.7 | Atraumatic - large | 3 years | none |
| 6 | 59 | no | 26.8 | Traumatic - massive | 1 month | none |
| 7 | 66 | no | 29.0 | Traumatic - massive | 4 months | none |
| 8 | 77 | no | 25.1 | Atraumatic - medium | 2 years | none |
| 9 | 60 | no | 28.7 | Atraumatic - large | 5 months | Physical therapy |
Male population: Mean age 61.67 ± 9.02; Mean age at surgery 62.33 ± 8.89; Mean BMI 28.23 ± 1.91; Mean duration of symptoms 13.33 ± 11.46 months
Fig. 1Withdrawal of the supraspinatus tendon bioptic sample during arthroscopic rotator cuff repair
Fig. 2Histomorphological analysis of the supraspinatus tendon alterations following the Bonar Scale criteria. A Haematoxylin/Eosin showed pathological rounded nuclei and an increased cytoplasm in tendon cells. B Alcian Blu highlighted ground substance abnormalities with increased intrafascicular and interfascicular deposits of GAG. C Masson-Goldner Trichrome showed pathological collagen arrangement, with disorganization of fibre bundles. D CD34 immunohistochemical staining showed pathological neovascularization. Original magnification: × 200 (A), × 100 (B, C, D)
Semiquantitative evaluation of tendon alterations in women according to the Bonar Scale
| Variables | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
| 0 (0%) | 3 (20%) | 8 (53.3%) | 4 (26.7%) | |
| 2 (13.3%) | 5 (33.3%) | 7 (46.7%) | 1 (6.7%) | |
| 0 (0%) | 0 (0%) | 12 (80%) | 3 (20%) | |
| 4 (26.7%) | 5 (33.3%) | 1 (6.7%) | 5 (33.3%) |
Data are absolute values and percentages of positively stained cells in women’s samples for the 4 parameters of the Bonar Scale: it allows a semiquantitative analysis of tendinopathy considering alterations of tenocytes, ground substance, collagen and vascularity. Each parameter is scored with a four-point scoring system, with 0 indicating healthy tissue and III highly degenerated tissue. The final score is comprised between 0 (normal tendon) and 12 (most severe abnormality detectable)
Semiquantitative evaluation of tendon alterations in men according to the Bonar Scale
| Variables | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
| 1 (11.1%) | 2 (22.2%) | 5 (55.6%) | 1 (11.1%) | |
| 3 (33.3%) | 4 (44.4%) | 2 (22.2%) | 0 (0%) | |
| 0 (0%) | 3 (33.3%) | 5 (55.6%) | 1 (11.1%) | |
| 2 (22.2%) | 5 (55.6%) | 0 (0%) | 2 (22.2%) |
Data are absolute values and percentages of positively stained cells in men’s samples for the 4 parameters of the Bonar Scale
Fig. 3Immunohistochemical expression of ER-α, ER-β and PR in tenocytes of the supraspinatus tendon. A ER-α. B ER-β. C PR. Original magnification: × 40
Fig. 4Immunohistochemical expression of ER-α, ER-β and PR in vascular cells of the supraspinatus tendon. A ER-α. B ER-β. C PR. Original magnification: × 40
Semiquantitative evaluation of ER-⍺, ER-β, PR expression in the supraspinatus tendon of women
| Variables | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
| 0 (0%) | 3 (20%) | 5 (33.3%) | 7 (46.7%) | |
| 9 (60%) | 4 (26.7%) | 1 (6.7%) | 1 (6.7%) | |
| 0 (0%) | 4 (26.7%) | 5 (33.3%) | 6 (40%) | |
| 8 (53.3%) | 4 (26.7%) | 3 (20%) | 0 (0%) | |
| 0 (0%) | 3 (20%) | 8 (53.3%) | 4 (26.7%) | |
| 8 (53.3%) | 3 (20%) | 3 (20%) | 1 (6.7%) |
Data are absolute values and percentages of positively stained cells in women’s samples for the expression of ER-⍺, ER-β, PR in the supraspinatus tendon: it was quantified considering four grades of diffuse immunoreactivity: 0 = no expression; 1 = weak expression; 2 = high expression; 3 = very high expression
Semiquantitative evaluation of ER-⍺, ER-β, PR expression in the supraspinatus tendon of men
| Variables | Grade 0 | Grade 1 | Grade 2 | Grade 3 |
|---|---|---|---|---|
| 0 (0%) | 5 (55.6%) | 3 (33.3%) | 1 (11.1%) | |
| 8 (88.9%) | 1 (11.1%) | 0 (0%) | 0 (0%) | |
| 1 (11.1%) | 4 (44.4%) | 4 (44.4%) | 0 (0%) | |
| 7 (77.8%) | 2 (22.2%) | 0 (0%) | 0 (0%) | |
| 2 (22.2%) | 5 (55.6%) | 2 (22.2%) | 0 (0%) | |
| 8 (88.9%) | 1 (11.1%) | 0 (0%) | 0 (0%) |
Data are absolute values and percentages of positively stained cells in men’s samples for the expression of ER-⍺, ER-β, PR in the supraspinatus tendon
Gender difference of expression for ER-⍺, ER-β, PR in the supraspinatus tendon
| ER-⍺ | ER-β | PR | ||||
|---|---|---|---|---|---|---|
| Females | Males | Females | Males | Females | Males | |
| Mean ± SD | 2.3 ± 0.8 | 1.6 ± 0.7 | 2.1 ± 0.8 | 1.3 ± 0.7 | 2.1 ± 0.7 | 1 ± 0.7 |
| N | 15 | 9 | 15 | 9 | 15 | 9 |
Statistical analysis highlighted a significant gender difference of immunoreactivity for ER-β (p = 0.048) and PR (p = 0.004), with postmenopausal women showing markedly higher levels of expression than men. No statistically significant differences were found between males and females in ER-⍺ tendon expression (p = 0.055). Data are expressed as mean ± SD